The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
Demand Trumps Distractions with Oil
It’s become apparent that Israel’s land war and Russia’s childish power plays aren’t driving gas prices up. In fact, the price of crude sank 6% to $38.00 a barrel this morning.
Demand destruction from the global recession has been able to trump the “saber rattlers” around the world trying to drive up prices. Neither can overcome the fact that U.S. crude inventories are at record highs. Supplies have been on a steady increase since fall and have been piling up in storage containers and ships around the world.
Stock prices of major gas producers have been volatile, but stable since October – when retail gas prices really started moving down. Producers Exxon Mobil (NYSE: XOM), Chevron (NYSE: CVX), BP (NYSE: BP), Royal Dutch Shell (NYSE: RDS.A) and ConocoPhillips (NYSE: COP) have all traded close to the S&P 500 Index (.INX).
The interesting thing is that gas supplies were large and stable during last summer’s price increases. It stands to reason that if the price of crude can be traded away from the demand once, it can happen again.
We predicted the price of crude could reach $20 a barrel late last year. But it wouldn’t be too far-fetched to suppose prices take an alternative tack after hitting a bottom. And a spike could be profitable for gas companies.
Companies mentioned in this article: XOM, CVX, BP, RDS.A and COP.
- Will The Price of Oil Per Barrel Drop to $20?
- OPEC: Lots of Oil, No Power
- The New Crude Oil Benchmark That Could Change the Oil Market’s Price Dynamics
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed